Efficacy and safety of intralesional 5-fluorouracil in treatment of warts

Tahir Kamal, Usma Iftikhar

Abstract


Objective To determine the efficacy and safety to intralesional 5-flourouracil in the treatment of common warts.

 

Methods This  interventional study was conducted in the Department of Dermatology, PGMI/AMC/Lahore General Hospital Lahore from October, 2016 to July, 2017. 40 patients with warts were treated with intralesional 5-FU (0.1ml/cm2 of 5-FU, 50mg/ml), at the base of each wart. Injections were repeated every two weeks, maximum for six injections. Patients followed fortnightly upto 2 months after last injection for efficacy and safety.

 

Results Overall 30 (75%) patients (of all types of warts) showed excellent results (maximum six injections) and remained clear on follow-up after 2 months of last treatment session. Localized irritation and pain were the major side effects encountered in all patients.

 

Conclusion Intralesional 5-FU is an effective and safe treatment for treatment of common, plantar and genital warts.

 


Keywords


Wart, 5-fluorouracil, intralesional

Full Text:

PDF

References


Li X, Yu J, Thomas S, Lee K, Soyer HP. Clinical and dermoscopic features of common warts. J Eur Acad Dermatol Venereol. 2017;31:e308-e310.

Haribakhti PB, Macwan R. Viral skin infections. In: Valia RG, Valia AR, editors. IADVL Textbook and Atlas of Dermatology 2nd edn. Mumbai: Bhalani Publishing House; 2001. P.303-9.

Gibbs S, Harvey I, sterling JC, Stark R. Local treatments for cutaneous warts. Cochrane Database Syst Rev. 2003;(3):Cd 001781.

Lemon JA, Benton EC. Verrucas. Guidelines for management. Am J Clin Dermatol. 2000;1:143-9.

Kubeyinje EP. Evaluation of the efficacy and safely 0.05% tretinoin cream in the treatment of lane warts in Arab Children. J Dermatol Treat. 1996;7:21-2.

Pringle WM, Helms DC. Treatment of Plantar warts by blunt dissection. Arch Dermatol. 1973;108:79-82.

Buckley D. Cryosurgery treatment of Plantar warts. Int Med J. 2000;93:140-3.

Streling JC, Handfield-Jones S, Hudson PM. Guidliness for the management of cutaneous warts. Br J Dermatol. 2001;144:4-11.

Fox PA, Tung Mr. Human Papilloma virus: burden of illness and treatment cost considerations. Am J Clin Dermatol. 2005;6:365-81.

Gnoshal K, Jacob ST, An alternative molecular mechanism of action of 5-fleorouracil, a Potent anticancer drug. Broche Pharmacol. 1997;53:1569-75.

Bunney MH. The treatment, of Plan warts with 5-fluorouracil. Br J Dermatol. 1973;89:96-7.

Iscimen A, Aydemir EH, Goksugar N, Engin B. Intralesional 5-fluorouracil, lidocaine and epinephrine mixture for the treatment of verrucae: a prospective placebo controlled, single-blind randomized study. J Eur Acad Dermatol Venereol. 2004;18:445-8.

Swinehart JM, Sperling M, Philips S, Kraus S, Gordon S, McCarty JM et al. Intralesional fluorouracil/epinephrine injectable gel for treatment of condylomata acuminate: A phase 3 clinical study. Arch Dermatol. 1997;133:67-73.

Yazdanfar A, Farshchian M, Fereydoonnejad M, Farshchian M. Treatment of common warts with an intralesional mixture of 5-fluorouracil, lidocaine, and epinephrine: a prospective placebo-controlled, double-blind randomized trial. Dermatol Surg. 2008;34:656-9.


Refbacks

  • There are currently no refbacks.


ISSN: 1560-9014